Who makes [F-18]SDM-8?

[F-18]SDM-8 is developed by Brigham and Women's Hospital.

Last reviewed 2026-04-20 · How we verify

[F-18]SDM-8

Brigham and Women's Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[F-18]SDM-8
Sponsor	Brigham and Women's Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[F-18]SDM-8 CI brief — competitive landscape report
[F-18]SDM-8 updates RSS · CI watch RSS
Brigham and Women's Hospital portfolio CI